Walter Wahli

Lausanne, VD 1015, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

The emerging role of PPARs in primary biliary cholangitis.

The emerging role of PPARs in primary biliary cholangitis.

Journal: Trends in molecular medicine

Published: February 27, 2026

Peroxisome Proliferator-Activated Receptor β/δ: A Link Between Metabolism, Inflammation, and Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Peroxisome Proliferator-Activated Receptor β/δ: A Link Between Metabolism, Inflammation, and Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Cells

Published: February 05, 2026

Hepatic FGF21 is not required for fasting metabolism but guides protein appetite post energy depletion.

Hepatic FGF21 is not required for fasting metabolism but guides protein appetite post energy depletion.

Journal: EMBO reports

Published: October 22, 2025

Palmitic and oleic acids in type 2 diabetes mellitus.

Palmitic and oleic acids in type 2 diabetes mellitus.

Journal: Trends in endocrinology and metabolism: TEM

Published: September 29, 2025

PPARβ/δ contributes to the antidiabetic effect and the increase in GDF15 caused by metformin.

PPARβ/δ contributes to the antidiabetic effect and the increase in GDF15 caused by metformin.

Journal: Acta pharmacologica Sinica

Published: July 17, 2025

Angptl4 integrates dietary and microbial signals to disrupt gut barrier function in MASH.

Angptl4 integrates dietary and microbial signals to disrupt gut barrier function in MASH.

Journal: Nature communications

Published: June 02, 2025

Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD.

Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD.

Journal: Trends in pharmacological sciences

Published: February 20, 2025

Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling.

Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling.

Journal: PLoS biology

Published: November 02, 2024

PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy.

PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy.

Journal: Pharmacological research

Published: September 10, 2024

PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels.

PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels.

Journal: Cell communication and signaling : CCS

Published: August 22, 2024

Lipid sensing by PPARα: Role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting.

Lipid sensing by PPARα: Role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting.

Journal: Progress in lipid research

Published: July 17, 2024

Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels.

Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels.

Journal: Cellular and molecular life sciences : CMLS

Published: June 15, 2024

Showing 1-12 of 115

Last Updated: 09/26/2026